Trials / Completed
CompletedNCT01155739
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
Etude Prospective Sur l'Impact de l'Utilisation de la Procalcitonine Dans l'évaluation de la Poursuite ou de l'arrêt du Traitement Antibiotique Empirique Lors de péritonites et d'Infections Intra-abdominales
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 162 (actual)
- Sponsor
- University of Lausanne Hospitals · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Procalcitonin level used for determining length of antibiotic treatment in peritonitis and intra-abdominal infections. Hypothesis is that length of antibiotic use can be shortened by this method.
Detailed description
Prospective randomized trial
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2010-07-02
- Last updated
- 2014-12-19
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01155739. Inclusion in this directory is not an endorsement.